94 related articles for article (PubMed ID: 23719240)
1. 5'-triphosphate-siRNA against survivin gene induces interferon production and inhibits proliferation of lung cancer cells in vitro.
Wang K; Chen X; Yan F; Xing Y; Yang X; Tu J; Chen Z
J Immunother; 2013 Jun; 36(5):294-304. PubMed ID: 23719240
[TBL] [Abstract][Full Text] [Related]
2. 5'-triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells.
Chen X; Qian Y; Yan F; Tu J; Yang X; Xing Y; Chen Z
Eur J Pharmacol; 2013 Dec; 721(1-3):86-95. PubMed ID: 24099962
[TBL] [Abstract][Full Text] [Related]
3. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
Zhang K; Li Y; Liu W; Gao X; Zhang K
Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
[TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin.
Yonesaka K; Tamura K; Kurata T; Satoh T; Ikeda M; Fukuoka M; Nakagawa K
Int J Cancer; 2006 Feb; 118(4):812-20. PubMed ID: 16108013
[TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenic efficacy of 5'-triphosphate siRNA combining VEGF silencing and RIG-I activation in NSCLCs.
Yuan D; Xia M; Meng G; Xu C; Song Y; Wei J
Oncotarget; 2015 Oct; 6(30):29664-74. PubMed ID: 26336994
[TBL] [Abstract][Full Text] [Related]
6. Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfection.
Walker T; Nolte A; Steger V; Makowiecki C; Mustafi M; Friedel G; Schlensak C; Wendel HP
Eur J Cardiothorac Surg; 2013 Mar; 43(3):628-33; discussion 633-4. PubMed ID: 23152437
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
Ji ZJ; Wang JL; Chen L
Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
[TBL] [Abstract][Full Text] [Related]
8. Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells.
Song H; Xin XY; Xiao F; Wang DT; Yue QH; Han X
Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):83-9. PubMed ID: 17098350
[TBL] [Abstract][Full Text] [Related]
9. 5'-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma.
Poeck H; Besch R; Maihoefer C; Renn M; Tormo D; Morskaya SS; Kirschnek S; Gaffal E; Landsberg J; Hellmuth J; Schmidt A; Anz D; Bscheider M; Schwerd T; Berking C; Bourquin C; Kalinke U; Kremmer E; Kato H; Akira S; Meyers R; Häcker G; Neuenhahn M; Busch D; Ruland J; Rothenfusser S; Prinz M; Hornung V; Endres S; Tüting T; Hartmann G
Nat Med; 2008 Nov; 14(11):1256-63. PubMed ID: 18978796
[TBL] [Abstract][Full Text] [Related]
10. Dual effects of duplex RNA harboring 5'-terminal triphosphate on gene silencing and RIG-I mediated innate immune response.
Baek SE; Kim H; Kim KB; Yoon S; Choe J; Suh W; Jeong YJ; Cho YH; Kim DE
Biochem Biophys Res Commun; 2015 Jan; 456(2):591-7. PubMed ID: 25490387
[TBL] [Abstract][Full Text] [Related]
11. A new strategy in the treatment of chemoresistant lung adenocarcinoma via specific siRNA transfection of SRF, E2F1, Survivin, HIF and STAT3.
Stoleriu MG; Steger V; Mustafi M; Michaelis M; Cinatl J; Schneider W; Nolte A; Kurz J; Wendel HP; Schlensak C; Walker T
Eur J Cardiothorac Surg; 2014 Nov; 46(5):877-86. PubMed ID: 24627437
[TBL] [Abstract][Full Text] [Related]
12. Effects and mechanism of downregulation of survivin expression by RNA interference on proliferation and apoptosis of lung cancer cells.
Chen XQ; Yang S; Li ZY; Lu HS; Kang MQ; Lin TY
Mol Med Rep; 2012 Apr; 5(4):917-22. PubMed ID: 22246162
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells.
Yang CT; Li JM; Weng HH; Li YC; Chen HC; Chen MF
Cancer Gene Ther; 2010 Feb; 17(2):120-30. PubMed ID: 19730451
[TBL] [Abstract][Full Text] [Related]
14. Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell.
Sun HB; Zheng HY; Yan X
Eur Rev Med Pharmacol Sci; 2014; 18(18):2678-86. PubMed ID: 25317803
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenesis and anticancer effects of a plasmid expressing both ENDO-VEGI151 and small interfering RNA against survivin.
Li Z; Yang S; Chang T; Cao X; Shi L; Fang G
Int J Mol Med; 2012 Mar; 29(3):485-90. PubMed ID: 22109572
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic efficacy of bifunctional siRNA combining TGF-β1 silencing with RIG-I activation in pancreatic cancer.
Ellermeier J; Wei J; Duewell P; Hoves S; Stieg MR; Adunka T; Noerenberg D; Anders HJ; Mayr D; Poeck H; Hartmann G; Endres S; Schnurr M
Cancer Res; 2013 Mar; 73(6):1709-20. PubMed ID: 23338611
[TBL] [Abstract][Full Text] [Related]
17. GABA
Ni S; Liu Y; Tang Y; Chen J; Li S; Pu J; Han L
Carbohydr Polym; 2018 Jan; 179():135-144. PubMed ID: 29111036
[TBL] [Abstract][Full Text] [Related]
18. siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.
Zhang Y; Chen ZD; Du CJ; Xu G; Luo W
Pathol Res Pract; 2009; 205(12):823-7. PubMed ID: 19628339
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
Zhang J; Wang S; Han F; Li J; Yu L; Zhou P; Chen Z; Xue S; Dai C; Li Q
Gene; 2016 Apr; 579(2):146-52. PubMed ID: 26723509
[TBL] [Abstract][Full Text] [Related]
20. Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7.
Bi Y; Zhang Y; Cui C; Ren L; Jiang X
Int J Nanomedicine; 2016; 11():5771-5787. PubMed ID: 27853365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
